<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> Epigenetic Biomarkers in Kidney Cancer | Xiaofan Lu </title> <meta name="author" content="Xiaofan Lu"> <meta name="description" content="Identifying DNA methylation signatures predictive of immunotherapy response in metastatic clear-cell renal cell carcinoma"> <meta name="keywords" content="bioinformatics, computational oncology, multi-omics, cancer research, immunotherapy, renal cell carcinoma"> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" href="/assets/css/scholar-icons.css?62b2ac103a88034e6882a5be5f3e2772"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="data:image/svg+xml,&lt;svg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%20100%22&gt;&lt;text%20y=%22.9em%22%20font-size=%2290%22&gt;%E2%9A%9B%EF%B8%8F&lt;/text&gt;&lt;/svg&gt;"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://siduparis.github.io/projects/2_epigenetics/"> <script src="/assets/js/theme.js?a81d82887dd692e91686b43de4542f18"></script> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script>
    initTheme();
  </script> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"> Xiaofan Lu </a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about </a> </li> <li class="nav-item "> <a class="nav-link" href="/blog/">blog </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item active"> <a class="nav-link" href="/projects/">projects <span class="sr-only">(current)</span> </a> </li> <li class="nav-item "> <a class="nav-link" href="/repositories/">repositories </a> </li> <li class="nav-item "> <a class="nav-link" href="/teaching/">teaching </a> </li> <li class="nav-item "> <a class="nav-link" href="/people/">people </a> </li> <li class="nav-item dropdown "> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">submenus </a> <div class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdown"> <a class="dropdown-item " href="/books/">bookshelf</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/blog/">blog</a> </div> </li> <li class="nav-item"> <button id="search-toggle" title="Search" onclick="openSearchModal()"> <span class="nav-link">ctrl k <i class="ti ti-search"></i></span> </button> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="ti ti-sun-moon" id="light-toggle-system"></i> <i class="ti ti-moon-filled" id="light-toggle-dark"></i> <i class="ti ti-sun-filled" id="light-toggle-light"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title">Epigenetic Biomarkers in Kidney Cancer</h1> <p class="post-description">Identifying DNA methylation signatures predictive of immunotherapy response in metastatic clear-cell renal cell carcinoma</p> </header> <article> <h2 id="background">Background</h2> <p>Metastatic clear-cell renal cell carcinoma (ccRCC) represents a major clinical challenge, with variable responses to immune checkpoint inhibitors (ICIs). My research addresses the critical need to predict treatment response through epigenetic profiling.</p> <h2 id="the-bionikk-trial">The BIONIKK Trial</h2> <p>This work is based on the <strong>BIONIKK clinical trial</strong> (NCT02960906), the first academic personalized clinical trial in metastatic ccRCC assessing patient response to:</p> <ul> <li>Nivolumab monotherapy</li> <li>Ipilimumab + Nivolumab (Ipi/Nivo)</li> <li>Sunitinib</li> </ul> <h2 id="key-discoveries">Key Discoveries</h2> <h3 id="1-tumor-enhancer-demethylation-ted-phenotype">1. Tumor Enhancer Demethylation (TED) Phenotype</h3> <div class="row"> <div class="col-sm mt-3 mt-md-0"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/ted_phenotype-480.webp 480w,/assets/img/ted_phenotype-800.webp 800w,/assets/img/ted_phenotype-1400.webp 1400w," type="image/webp" sizes="95vw"></source> <img src="/assets/img/ted_phenotype.jpg" class="img-fluid rounded z-depth-1" width="100%" height="auto" title="TED phenotype" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <p><strong>Key findings</strong>:</p> <ul> <li>Identified a novel ccRCC subgroup defined by tumor enhancer demethylation</li> <li>Strongly associated with <strong>primary resistance</strong> to first-line Ipi/Nivo therapy</li> <li>Characterized by aggressive clinical features and poor outcomes</li> <li>Frequent sarcomatoid differentiation</li> </ul> <p><strong>Molecular mechanisms</strong>:</p> <ul> <li>TET1 promoter demethylation</li> <li>Activation of epithelial-mesenchymal transition (EMT)</li> <li>IL-6/JAK/STAT3 signaling activation</li> <li>Distinctive TME: immune activation + immunosuppression, fibroblast enrichment, endothelial depletion</li> </ul> <p><strong>Publication</strong>: Lu et al., <em>Clinical Cancer Research</em> (2022)</p> <h3 id="2-epigenetic-silencing-index-imes">2. Epigenetic Silencing Index (iMES)</h3> <div class="row"> <div class="col-sm mt-3 mt-md-0"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/imes_framework-480.webp 480w,/assets/img/imes_framework-800.webp 800w,/assets/img/imes_framework-1400.webp 1400w," type="image/webp" sizes="95vw"></source> <img src="/assets/img/imes_framework.jpg" class="img-fluid rounded z-depth-1" width="100%" height="auto" title="iMES framework" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <p><strong>Objective</strong>: Predict primary resistance to immune checkpoint inhibitors</p> <p><strong>Approach</strong>:</p> <ul> <li>Developed a methylation-based epigenetic silencing index (iMES)</li> <li>Validated across independent ccRCC cohorts</li> <li>Robust predictor of immunotherapy response</li> </ul> <p><strong>iMES-high tumor characteristics</strong>:</p> <ul> <li>Non-permissive tumor microenvironment</li> <li>Concurrent immune activation and suppression</li> <li>EZH2 activation</li> <li>Frequent BAP1 or SETD2 alterations</li> <li>Epigenetic silencing of VEGF receptor genes</li> <li>Reduced endothelial component in TME</li> </ul> <p><strong>Clinical significance</strong>: Challenges the prevailing belief that ccRCC with angiogenic signature benefits solely from anti-angiogenic agents</p> <p><strong>Publication</strong>: Lu et al., <em>Cell Reports Medicine</em> (2023)<br> <strong>Software</strong>: <a href="https://github.com/xlucpu/iMES" rel="external nofollow noopener" target="_blank">iMES R package</a></p> <h2 id="clinical-impact">Clinical Impact</h2> <p>These complementary epigenetic biomarker frameworks enable:</p> <ul> <li> <strong>Robust prediction</strong> of immunotherapy response</li> <li> <strong>Treatment stratification</strong> for personalized therapy selection</li> <li> <strong>Mechanistic understanding</strong> of resistance mechanisms</li> </ul> <h2 id="recognition">Recognition</h2> <ul> <li> <strong>Editorial</strong>: Zhou and Kim, <em>Clinical Cancer Research</em> (2023) - “Viewing RCC with a DNA Methylation Lens ENHANCES Understanding of ICI Resistance”</li> <li> <strong>Oral presentations</strong>: <ul> <li>ARC Symposium for Signatures in Cancer Immunotherapy (Paris, 2023)</li> <li>1ères Journées de recherche en Immuno-Oncologie (Strasbourg, 2025)</li> <li>12th FMTS Scientific Meeting (Strasbourg, 2025)</li> </ul> </li> <li> <strong>Award</strong>: Young Researcher Oncology Prize (2025)</li> </ul> <h2 id="future-directions">Future Directions</h2> <p>The identification of TED and iMES provides a foundation for:</p> <ul> <li>Epigenetic biomarker-driven clinical trials</li> <li>Development of combination therapies targeting epigenetic vulnerabilities</li> <li>Personalized treatment selection in metastatic ccRCC</li> </ul> </article> <h2>References</h2> <div class="publications"> </div> </div> </div> <footer class="fixed-bottom" role="contentinfo"> <div class="container mt-0"> © Copyright 2026 Xiaofan Lu. Powered by <a href="https://jekyllrb.com/" target="_blank" rel="external nofollow noopener">Jekyll</a> with <a href="https://github.com/alshedivat/al-folio" target="_blank" rel="external nofollow noopener">al-folio</a> theme. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@5.0.0/imagesloaded.pkgd.min.js" integrity="sha256-htrLFfZJ6v5udOG+3kNLINIKh2gvoKqwEhHYfTTMICc=" crossorigin="anonymous"></script> <script defer src="/assets/js/masonry.js?a0db7e5d5c70cc3252b3138b0c91dcaf" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?2781658a0a2b13ed609542042a859126"></script> <script defer src="/assets/js/common.js?c15de51d4bb57887caa2c21988d97279"></script> <script defer src="/assets/js/copy_code.js?c8a01c11a92744d44b093fc3bda915df" type="text/javascript"></script> <script defer src="/assets/js/jupyter_new_tab.js?d9f17b6adc2311cbabd747f4538bb15f"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/tex-mml-chtml.js" integrity="sha256-MASABpB4tYktI2Oitl4t+78w/lyA+D7b/s9GEP0JOGI=" crossorigin="anonymous"></script> <script src="/assets/js/mathjax-setup.js?a5bb4e6a542c546dd929b24b8b236dfd"></script> <script defer src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" crossorigin="anonymous"></script> <script defer src="/assets/js/progress-bar.js?2f30e0e6801ea8f5036fa66e1ab0a71a" type="text/javascript"></script> <script src="/assets/js/vanilla-back-to-top.min.js?f40d453793ff4f64e238e420181a1d17"></script> <script>
    addBackToTop();
  </script> <script type="module" src="/assets/js/search/ninja-keys.min.js?a3446f084dcaecc5f75aa1757d087dcf"></script> <ninja-keys hidebreadcrumbs noautoloadmdicons placeholder="Type to start searching"></ninja-keys> <script src="/assets/js/search-setup.js?6c304f7b1992d4b60f7a07956e52f04a"></script> <script src="/assets/js/search-data.js"></script> <script src="/assets/js/shortcut-key.js?6f508d74becd347268a7f822bca7309d"></script> </body> </html>